Fig. 1From: Rilpivirine use in the Swiss HIV cohort study: a prospective cohort studyFlowchart of patients initiating RPV/TDF/FTC co-formulation, discontinuation and treatment failures. *Discontinuation for other reasons than virological failure Vl viral load, cART combined antiretroviral therapyBack to article page